We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.2%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$53.7B
AUM Growth
-$2.95B
(-5.2%)
Cap. Flow
+$168M
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
35.03%
Holding
1,742
New
57
Increased
475
Reduced
481
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$234M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$120M |
| 3 |
Micron Technology
MU
|
+$114M |
| 4 |
CoStar Group
CSGP
|
+$112M |
| 5 |
Linde
LIN
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTAI Aviation
FTAI
|
+$421M |
| 2 |
AbbVie
ABBV
|
+$174M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$126M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$107M |
| 5 |
Capital One
COF
|
+$84.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.44% |
| 2 | Financials | 12.06% |
| 3 | Healthcare | 11.81% |
| 4 | Communication Services | 9.87% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
United States Antimony
UAMY
$865M
| $50.6K | ﹤0.01% |
+5,800
| New | +$50.6K |
|
1677
Calumet Specialty Products
CLMT
$3.85B
| $48.5K | ﹤0.01% |
+1,350
| New | +$35K |
|
1678
PRA Group
PRAA
$666M
| $48K | ﹤0.01% |
2,740
+200
| +8% | +$3.04K |
|
1679
Great Southern Bancorp
GSBC
$857M
| $47.9K | ﹤0.01% |
759
| – | – |
|
1680
Alignment Healthcare
ALHC
$4.44B
| $47.6K | ﹤0.01% |
+2,700
| New | +$54.2K |
|
|
AAT
1681
American Assets Trust
AAT
$1.55B
| $47.1K | ﹤0.01% |
2,557
| – | – |
|
1682
TETRA Technologies
TTI
$1.35B
| $46.9K | ﹤0.01% |
+5,500
| New | +$55.1K |
|
1683
NETGEAR
NTGR
$650M
| $46.7K | ﹤0.01% |
2,140
| – | – |
|
1684
New Jersey Resources
NJR
$5.89B
| $45.2K | ﹤0.01% |
823
| – | – |
|
1685
Dave & Buster's
PLAY
$371M
| $43.8K | ﹤0.01% |
4,048
| – | – |
|
|
DEC
1686
Diversified Energy Company
DEC
$920M
| $42.7K | ﹤0.01% |
2,451
| – | – |
|
1687
Certara
CERT
$1.07B
| $39.8K | ﹤0.01% |
6,977
| – | – |
|
1688
Capricor Therapeutics
CAPR
$1.15B
| $39.5K | ﹤0.01% |
+1,300
| New | +$34.6K |
|
1689
Bristow Group
VTOL
$1.34B
| $39.4K | ﹤0.01% |
841
| – | – |
|
|
USAR
1690
USA Rare Earth Inc
USAR
$3.87B
| $39.4K | ﹤0.01% |
+2,600
| New | +$50.4K |
|
1691
Phreesia
PHR
$655M
| $38.5K | ﹤0.01% |
4,591
| – | – |
|
1692
Vitesse Energy
VTS
$664M
| $38.1K | ﹤0.01% |
2,098
| – | – |
|
1693
Apogee Enterprises
APOG
$816M
| $36.9K | ﹤0.01% |
1,101
| – | – |
|
1694
Cricut
CRCT
$942M
| $35.2K | ﹤0.01% |
+9,400
| New | +$41.2K |
|
1695
F&G Annuities & Life
FG
$4B
| $35.1K | ﹤0.01% |
1,385
-2,248
| -62% | -$58.6K |
|
1696
Redwire
RDW
$2.25B
| $33.1K | ﹤0.01% |
+3,900
| New | +$38.2K |
|
1697
Myriad Genetics
MYGN
$558M
| $33.1K | ﹤0.01% |
7,356
| – | – |
|
1698
Forward Air
FWRD
$513M
| $31.7K | ﹤0.01% |
1,897
+50
| +3% | +$1.22K |
|
1699
Rapid7
RPD
$709M
| $31.3K | ﹤0.01% |
5,686
| – | – |
|
1700
Blackstone Mortgage Trust
BXMT
$2.83B
| $31.3K | ﹤0.01% |
1,636
+100
| +7% | +$1.93K |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Ensign Peak Advisors held 1,742 positions worth $53.7B, down 5.2% from $56.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Ensign Peak Advisors's Q1 2026 filing shows 57 new, 475 increased, 481 reduced and 34 closed positions. Its largest new stake was Novo Nordisk: 400,384 shares worth $14.7M. The largest sale was FTAI Aviation, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.
- Ensign Peak Advisors's largest Q1 2026 buy was Novo Nordisk: 400,384 shares worth $14.7M.
- Ensign Peak Advisors added most to Boston Scientific in Q1 2026, an estimated $234M increase.
- Ensign Peak Advisors's biggest Q1 2026 reduction was FTAI Aviation, cutting an estimated $421M.
- Ensign Peak Advisors fully exited Exact Sciences in Q1 2026, selling an estimated $17M.
- Ensign Peak Advisors's ten largest holdings make up 35% of its $53.7B portfolio in Q1 2026.
- Ensign Peak Advisors opened 57 new positions and closed 34 in Q1 2026.
- Ensign Peak Advisors's portfolio value fell 5.2% quarter-over-quarter to $53.7B.
Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.